Core Insights - Eastman Chemical Company (EMN) reported second-quarter 2025 earnings of $1.20 per share, a decline of approximately 38% from $1.94 in the same quarter last year [1] - Adjusted earnings were $1.60 per share, down from $2.15 year-over-year, and below the Zacks Consensus Estimate of $1.72 [1][9] - Revenues for the second quarter were $2,287 million, a decrease of around 3% year-over-year, missing the Zacks Consensus Estimate of $2,289.9 million [1][9] Financial Performance - Cash and cash equivalents at the end of the quarter stood at $423 million, with net debt at $4,703 million [6] - Cash provided by operating activities was $233 million, down approximately 37% year-over-year [6] - The company returned $145 million to shareholders through dividends and share repurchases during the quarter [6] Segment Performance - Advanced Materials segment sales fell 2% year-over-year to $777 million, beating the estimate of $770 million [3] - Additives & Functional Products segment sales increased by 7% year-over-year to $769 million, surpassing the estimate of $732 million [4] - Chemical Intermediaries segment sales decreased by 10% year-over-year to $463 million, missing the estimate of $529 million [5] - Fibers segment reported sales of $274 million, down 17% year-over-year, but beating the estimate of $252 million [5] Market Outlook - The company is facing significant challenges in the second quarter, with only modest signs of seasonal improvement across end markets [2] - EMN anticipates a challenging global macroeconomic environment in the second half, with cautious customer behavior due to changing tariffs and soft demand [7] - The company expects third-quarter adjusted earnings to be approximately $1.25 per share and aims for an operating cash flow of around $1 billion for the full year [7][9] Stock Performance - EMN's shares have declined by 25.5% over the past year, compared to a 22.8% decline in the Zacks Chemicals Diversified industry [10]
Eastman Chemical's Q2 Earnings and Revenues Miss, Down Y/Y